# P2-B Evidence Package — Index

**Horizon:** 1 (Architecture Foundation Framework)  
**Phase:** P2-B (Provider Integration & Architecture Validation)  
**Document Type:** Evidence Package Index  
**Date:** 2026-07-11  
**Authority:** Chief Architect

---

## Purpose

This document is the **master index** for all P2-B evidence artifacts.

**Critical Principle:**

> **Every evidence artifact MUST be indexed here for discoverability and reviewability.**

---

## Evidence Package Structure

```
.ai/reviews/horizon-1/p2-b-evidence/
├── 00-EVIDENCE-QUALITY-FRAMEWORK.md       (Evidence quality standards)
├── 01-ISSUE-CLASSIFICATION-FRAMEWORK.md   (Issue/Limitation/Debt classification)
├── 02-ADR-TRACEABILITY-MATRIX.md          (ADR ↔ Evidence mapping)
├── 03-EVIDENCE-INDEX.md                    (THIS FILE - master index)
├── P2-B-RISK-MITIGATION-PLAN.md           (Risk mitigation strategies)
├── ARCHITECTURE-DEBT-REGISTER.md          (Architecture debt tracking)
├── evidence/                               (Evidence artifacts subdirectory)
│   ├── EVD-001-L3-provider-swap-test.md
│   ├── EVD-002-L3-ci-pipeline-green.md
│   ├── EVD-003-L2-deployment-validation.md
│   └── ...
└── reviews/                                (Independent review artifacts)
    ├── REVIEW-001-p2-b-architecture-assessment.md
    └── ...
```

---

## Framework Documents

### 00-EVIDENCE-QUALITY-FRAMEWORK.md

**Status:** ✅ CREATED (2026-07-11)

**Purpose:**

- Define 4 evidence quality levels (L1-L4)
- Define evidence acceptance criteria (9 questions)
- Define verdict confidence matrix
- Define evidence labeling standard

**Key Concepts:**

- L1: Observational Evidence
- L2: Documented Evidence
- L3: Automated Evidence
- L4: Adversarial Evidence

**Cross-Reference:** P2-B-DEFINITION-OF-DONE.md, P2-B-RISK-MITIGATION-PLAN.md

---

### 01-ISSUE-CLASSIFICATION-FRAMEWORK.md

**Status:** ✅ CREATED (2026-07-11)

**Purpose:**

- Define classification for findings (Issue/Limitation/Debt)
- Prevent over-classification as "debt"
- Define classification decision tree

**Key Concepts:**

- Issue: Deviation from specification (fix now)
- Limitation: Known boundary within scope (document, monitor)
- Architecture Debt: Requires architectural evolution (register, plan)

**Cross-Reference:** ARCHITECTURE-DEBT-REGISTER.md

---

### 02-ADR-TRACEABILITY-MATRIX.md

**Status:** ✅ CREATED (2026-07-11)

**Purpose:**

- Map ADRs to Evidence artifacts
- Map Evidence to Success Criteria
- Map Evidence to Quality Attributes
- Ensure bidirectional traceability

**Key Concepts:**

- Forward Traceability (ADR → Evidence)
- Backward Traceability (Evidence → ADR)
- Traceability Validation Checklist

**Cross-Reference:** ARCHITECTURE-DECISION-RECORD-INDEX.md, SUCCESS-CRITERIA-PER-LEVEL.md, QUALITY-ATTRIBUTE-SCENARIOS.md

---

### 03-EVIDENCE-INDEX.md

**Status:** ✅ CREATED (2026-07-11)

**Purpose:**

- Master index of all evidence artifacts
- Evidence statistics and metrics
- Evidence review status

**This Document.**

---

### P2-B-RISK-MITIGATION-PLAN.md

**Status:** ✅ CREATED (2026-07-11)

**Purpose:**

- Identify P2-B risks
- Define mitigation strategies
- Track risk status

**Risks:**

- RISK-1: Evidence Quality
- RISK-2: ADR Traceability
- RISK-3: Evidence Accumulation
- RISK-4: Evidence Independence

**Cross-Reference:** 00-EVIDENCE-QUALITY-FRAMEWORK.md, 02-ADR-TRACEABILITY-MATRIX.md

---

### ARCHITECTURE-DEBT-REGISTER.md

**Status:** ✅ CREATED (2026-07-11)

**Purpose:**

- Track known architectural compromises
- Document rationale and trigger conditions
- Monitor debt accumulation

**Current Debt Items:** 0 (P2-B not started yet)

**Cross-Reference:** 01-ISSUE-CLASSIFICATION-FRAMEWORK.md

---

## Evidence Artifacts

**Status:** 📋 NO ARTIFACTS YET (P2-B not started)

**Expected Evidence (P0 ADRs):**

### ADR-1001: Provider Abstraction Strategy

- [ ] EVD-001-L3-provider-swap-test.md
- [ ] EVD-002-L3-provider-abstraction-test-suite.md
- [ ] EVD-003-L3-zero-consumer-changes-validation.md

### ADR-1006: Provider Credential Management

- [ ] EVD-010-L3-credential-storage-test.md
- [ ] EVD-011-L3-credential-rotation-test.md
- [ ] EVD-012-L2-code-review-no-secrets.md

### ADR-1050: ACOS Observability Strategy

- [ ] EVD-020-L3-trace-completeness-test.md
- [ ] EVD-021-L3-observability-explains-why.md
- [ ] EVD-022-L2-trace-example-end-to-end.md

### ADR-1053: ACOS Deployment Model

- [ ] EVD-030-L3-deployment-logs.md
- [ ] EVD-031-L3-health-check-response.md
- [ ] EVD-032-L3-studio-integration-test-production.md

---

## Evidence Statistics

**Current Status (2026-07-11):**

| Metric | Count | Target |
|--------|-------|--------|
| Total Evidence Artifacts | 0 | ≥20 |
| L1 Evidence | 0 | - |
| L2 Evidence | 0 | ≥5 |
| L3 Evidence | 0 | ≥10 |
| L4 Evidence | 0 | ≥2 |
| Orphan Evidence (no ADR) | 0 | 0 |
| ADRs Without Evidence | 4 (P0 ADRs not written yet) | 0 |

**Target Status (P2-B Completion):**

| Metric | Target |
|--------|--------|
| Total Evidence Artifacts | ≥20 |
| L3 Evidence | ≥10 (all critical claims) |
| L2 Evidence | ≥5 (documentation/manual validation) |
| L4 Evidence | ≥2 (resilience/stress testing) |
| Orphan Evidence | 0 |
| ADRs Without Evidence | 0 |

---

## Evidence Quality Distribution

**Current Distribution:**

| Quality Level | Count | Percentage | Target |
|--------------|-------|------------|--------|
| L1 | 0 | 0% | - |
| L2 | 0 | 0% | ≥25% |
| L3 | 0 | 0% | ≥50% |
| L4 | 0 | 0% | ≥10% |

**Target Distribution (P2-B Completion):**

| Quality Level | Target Count | Target Percentage |
|--------------|--------------|-------------------|
| L1 | 0 | 0% (no L1 evidence accepted) |
| L2 | ≥5 | ≥25% |
| L3 | ≥10 | ≥50% |
| L4 | ≥2 | ≥10% |

---

## Evidence Review Status

**Review Gates:**

1. **Evidence Acceptance Review** (per artifact)
   - Quality level assigned
   - 9 acceptance criteria questions answered
   - Traceability to ADR/Success Criteria/Quality Attribute
   - Reproducibility documented

2. **Traceability Review** (per phase)
   - All ADRs have evidence
   - All evidence traces to ADR
   - No orphan evidence artifacts

3. **Architecture Assessment Review** (P2-B completion)
   - Evidence Package complete
   - All success criteria validated
   - Stage 1.0 baseline validated or revised

**Current Review Status:**

- [ ] Evidence Acceptance Review (0/0 artifacts reviewed)
- [ ] Traceability Review (not started)
- [ ] Architecture Assessment Review (not started)

---

## Evidence Naming Convention

**Standard Format:**

```
EVD-<id>-<quality-level>-<short-description>.md

Components:
- <id>: Zero-padded 3-digit number (001, 002, 003, ...)
- <quality-level>: L1, L2, L3, or L4
- <short-description>: Kebab-case short description (e.g., provider-swap-test)
```

**Examples:**

✅ **Good:**
- `EVD-001-L3-provider-swap-test.md`
- `EVD-002-L3-ci-pipeline-green.md`
- `EVD-003-L2-deployment-validation.md`

❌ **Bad:**
- `evidence1.md` (no quality level, no structure)
- `EVD-1-provider-test.md` (id not zero-padded)
- `EVD-001-provider-swap-test.md` (no quality level)

---

## Evidence Front Matter Template

**Every evidence artifact MUST include this front matter:**

```yaml
---
evidence-id: EVD-XXX
quality-level: L3
claim: [Architectural claim being validated]
adr-reference: ADR-XXXX
success-criteria: [Reference to SUCCESS-CRITERIA-PER-LEVEL.md]
quality-attribute: [Reference to QUALITY-ATTRIBUTE-SCENARIOS.md]
test-date: [YYYY-MM-DD]
commit: [Git commit hash]
reviewer: [Reviewer name]
status: [Pending/Accepted/Rejected]
---
```

---

## Incremental Evidence Assembly Process

**During P2-B Implementation:**

```
1. ADR Written
    ↓
2. Implementation
    ↓
3. Automated Test
    ↓
4. Evidence Captured
    ↓
5. Evidence Artifact Created (EVD-XXX-LX-*.md)
    ↓
6. Evidence Index Updated (THIS FILE)
    ↓
7. Traceability Matrix Updated (02-ADR-TRACEABILITY-MATRIX.md)
    ↓
8. Evidence Review
    ↓
9. Evidence Accepted ✅
```

**Frequency:**

- Evidence Index updated: **per evidence artifact**
- Traceability Matrix updated: **per evidence artifact**
- Statistics updated: **weekly**
- Complete review: **P2-B completion**

---

## Governance Rules

### Rule 1: All Evidence MUST Be Indexed

> If an evidence artifact exists, it MUST be indexed in this document.

**No hidden evidence.**

---

### Rule 2: Index MUST Be Updated Incrementally

> Evidence Index updated per artifact, not at the end of P2-B.

**Process:**

```
Evidence Created → Index Updated → Commit
```

**Rationale:**

- Prevents evidence accumulation chaos
- Enables continuous review
- Ensures discoverability

---

### Rule 3: Statistics MUST Be Accurate

> Evidence statistics reflect actual state (not aspirational).

**Update Frequency:** Weekly during P2-B

---

## Anti-Patterns

### ❌ Anti-Pattern 1: Evidence Without Index Entry

**Example:**

> Evidence artifact created: `EVD-001-L3-provider-swap-test.md`
> 
> Index entry: (none)

**Why Wrong:**

- Evidence not discoverable
- Cannot track progress

**Correct Approach:**

- Create evidence artifact
- Add entry to Evidence Index
- Update statistics

---

### ❌ Anti-Pattern 2: Index Updated at End Only

**Example:**

> "Let's wait until P2-B is complete, then update the index."

**Why Wrong:**

- Evidence accumulates without organization
- Continuous review impossible

**Correct Approach:**

- Update index incrementally (per artifact)

---

### ❌ Anti-Pattern 3: Stale Statistics

**Example:**

> "Statistics last updated: 2 weeks ago"

**Why Wrong:**

- Cannot track progress
- Cannot identify gaps

**Correct Approach:**

- Update statistics weekly during P2-B

---

## Summary

**Evidence Package Index Purpose:**

1. Master index of all evidence artifacts
2. Evidence statistics and metrics
3. Evidence review status tracking
4. Incremental assembly process enforcement

**Governance:**

- All evidence MUST be indexed
- Index MUST be updated incrementally
- Statistics MUST be accurate

**Outcome:**

> If P2-B maintains accurate Evidence Index, Architecture Assessment can efficiently review all evidence and produce high-confidence verdict.

---

## Next Steps (P2-B Implementation)

**When P2-B implementation begins:**

1. ✅ Evidence directory structure created
2. ✅ Framework documents created
3. ⏳ Write P0 ADRs (ADR-1001, ADR-1006, ADR-1050, ADR-1053)
4. ⏳ Implement provider abstraction
5. ⏳ Capture evidence incrementally
6. ⏳ Update Evidence Index per artifact
7. ⏳ Update Traceability Matrix per artifact
8. ⏳ Complete Evidence Package
9. ⏳ Architecture Assessment Review

---

**Document Version:** 1.0 (LIVING DOCUMENT)  
**Date:** 2026-07-11  
**Status:** Active Index (Updated Incrementally During P2-B)  
**Authority:** Chief Architect  
**Cross-Reference:** 00-EVIDENCE-QUALITY-FRAMEWORK.md, 01-ISSUE-CLASSIFICATION-FRAMEWORK.md, 02-ADR-TRACEABILITY-MATRIX.md, P2-B-DEFINITION-OF-DONE.md
